Global Blue-Chip Stocks Receive Analyst Recommendations

Strategic Insights -

On Monday and Tuesday, several global blue-chip stocks received analyst recommendations from top financial institutions. In the consumer goods sector, JPMorgan cut Tesla's price target to 125 USD, citing an "underweight" stance. Exane BNP Paribas also made changes to its Apple rating, cutting it to "neutral" with a price target of 140 USD. Meanwhile, Goldman Sachs reduced its Diageo price target to 4700 pence, while maintaining a "buy" rating. Barclays followed suit by cutting Reckitt Benckiser's price target to 7800 pence, but still maintained an "overweight" rating.

In the consumer services sector, RBC raised Inditex to its top 30 global ideas for 2023, with an "outperform" rating. In the financials sector, Jefferies raised BNP Paribas' price target to 77 EUR, while Barclays increased JPMorgan Chase's price target to 189 USD. In the health care sector, JPMorgan made several changes, including cutting Bayer to "neutral" and raising Novo Nordisk's price target to 1100 DKK. The bank also raised AstraZeneca's price target to 13500 pence, while cutting GSK to "underweight".

In the industrials sector, Redburn raised CRH to "buy", while Jefferies cut Thales to "hold" and raised Safran's price target to 118 EUR. Jefferies also increased Airbus' price target to 135 EUR. In the technology sector, RBC raised Meta Platforms to its top 30 global ideas for 2023, with an "outperform" rating. Finally, in the utilities sector, Jefferies cut SSE to "hold" and reduced its price target to 1830 pence.

Key Takeaways:

  • JPMorgan cut Tesla's price target to 125 USD, citing an "underweight" stance.
  • Exane BNP Paribas cut Apple to "neutral" with a price target of 140 USD.
  • Goldman Sachs reduced its Diageo price target to 4700 pence.
  • Barclays cut Reckitt Benckiser's price target to 7800 pence, but maintained an "overweight" rating.
  • RBC raised Inditex to its top 30 global ideas for 2023 with an "outperform" rating.
  • Jefferies raised BNP Paribas' price target to 77 EUR, while Barclays increased JPMorgan Chase's price target to 189 USD.
  • JPMorgan made several changes in the health care sector, including cutting Bayer to "neutral" and raising Novo Nordisk's price target to 1100 DKK.
  • Redburn raised CRH to "buy", while Jefferies cut Thales to "hold" and raised Safran's price target to 118 EUR.
  • RBC raised Meta Platforms to its top 30 global ideas for 2023 with an "outperform" rating.

Statistics:

  • JPMorgan cut Tesla's price target to 125 USD.
  • Exane BNP Paribas cut Apple's rating to "neutral" with a price target of 140 USD.
  • Goldman Sachs reduced its Diageo price target to 4700 pence.
  • Barclays cut Reckitt Benckiser's price target to 7800 pence.
  • RBC raised Inditex to its top 30 global ideas for 2023 with an "outperform" rating.
  • JPMorgan raised Novo Nordisk's price target to 1100 DKK.
  • Jefferies raised Airbus' price target to 135 EUR.
  • RBC raised Meta Platforms to its top 30 global ideas for 2023 with an "outperform" rating.

Sources:

  • Alliance News Ltd. -
  • JPMorgan
  • Exane BNP Paribas
  • Goldman Sachs
  • Barclays
  • RBC
  • Jefferies